Evaluation of PSI, CURB-65, and CRB-65 as prognostic tools in hospitalized immunocompetent patients with pneumonia: real-world outcomes from internal medicine wards [0.03%]
评估PSI、CURB-65和CRB-65作为免疫 competent肺炎住院患者的预后工具：内科病房的真实世界结果
Alon Pomerantz,Adar Yaacov,Adam Goldman et al.
Alon Pomerantz et al.
Background: Pneumonia remains a leading cause of morbidity and mortality globally, necessitating reliable clinical prediction tools to guide medical management decisions. The Pneumonia Severity Index (PSI), CURB-65, and C...
Cynthia Terrones-Campos,Antonio Gallardo-Pizarro,Ana Martinez-Urrea et al.
Cynthia Terrones-Campos et al.
Invasive pulmonary aspergillosis (IPA) is a life-threatening fungal infection traditionally associated with severely immunocompromised hosts, particularly those with hematologic malignancies. However, its epidemiological profile has shifted...
Diagnostic BioFire® FilmArray® Pneumonia Panel Plus versus standard microbial culture in bronchiectasis exacerbations [0.03%]
用于支气管扩张急性加重的BioFire®FilmArray®肺炎panel plus与标准微生物培养的诊断价值比较
Patricia Oscanoa-Huamán,Leticia Bueno,Roberto Cabrera et al.
Patricia Oscanoa-Huamán et al.
Background: The diagnostic performance of the BioFire® FilmArray® Pneumonia Panel Plus (FAPP) compared to standard microbial culture (SMC) during bronchiectasis (BE) exacerbations is unknown. ...
Investigating risk factors for methicillin-resistant Staphylococcus aureus and Pseudomonas aeruginosa in community acquired pneumonia: a model for using only electronic data capture [0.03%]
利用仅电子数据采集调查社区获得性肺炎中耐甲氧西林金黄色葡萄球菌和铜绿假单胞菌的风险因素：一项研究模型
Philip Logan Whitfield,Kristen Wendler,Rachel Gabor et al.
Philip Logan Whitfield et al.
Background: The 2019 American Thoracic Society and Infectious Diseases Society of America community acquired pneumonia guidelines recommend empiric coverage of methicillin-resistant Staphylococcus aureus and Pseudomonas a...
Influence of area-level social vulnerability on all-cause pneumonia, all-cause acute otitis media, and invasive pneumococcal disease incidence among Medicaid-enrolled children [0.03%]
社会脆弱性对儿童肺炎、急性中耳炎和侵袭性肺炎链球菌病发病的影响
Salini Mohanty,Michael Barna,Kelsie Cassell et al.
Salini Mohanty et al.
Background: The incidence of pneumococcal disease differs based on demographic and clinical factors, yet the impact of area-level social determinants of health, particularly for children, remains less understood. We chara...
Pneumocystis pneumonia in older non-HIV-infected patients: a French, multicentre, retrospective, cohort study [0.03%]
法国多中心回顾性队列研究中非HIV感染的老年人患肺炎链球菌肺炎的情况
Adrien Barraud,Romaric Larcher,Gaëtan Gavazzi et al.
Adrien Barraud et al.
Background: Pneumocystis pneumonia (PCP) is well-described in younger and HIV-infected populations, but limited data are available for older non-HIV-infected patients. The aim was to describe the clinical characteristics,...
Lucia Alessandra Pasqua,Catia Cilloniz,Antoni Torres
Lucia Alessandra Pasqua
Hospital-acquired pneumonia (HAP) is a serious infection with high mortality rates, especially in critically ill patients. The role of corticosteroids as adjunctive therapy in this population is debated. These agents have anti-inflammatory ...
Pneumococcal carriage and disease in adults hospitalised with community-acquired pneumonia in Mongolia: prospective pneumonia surveillance program (2019-2022) [0.03%]
蒙古住院的社区获得性肺炎成人患者的肺炎链球菌定植和疾病：2019-2022年前瞻性肺炎监测项目
Tuya Mungun,Munkhchuluun Ulziibayar,Cattram D Nguyen et al.
Tuya Mungun et al.
Background: Streptococcus pneumoniae is an important cause of pneumonia in older adults, however, serotyping and indirect impact information from low and middle-income countries is lacking. Mongolia has a childhood 13-val...
Individualized treatment rule for early steroid use in hospitalized patients with community acquired pneumonia: a cohort study [0.03%]
社区获得性肺炎住院患者的早期糖皮质激素使用个体化治疗方案：群组研究
Yewande E Odeyemi,Allison M LeMahieu,Erin F Barreto et al.
Yewande E Odeyemi et al.
Background: Current evidence on an optimal patient selection strategy for adjunctive steroids to curb excessive inflammation in community acquired pneumonia (CAP) is limited. An individualized treatment rule (ITR) customi...
Immunosuppressed patients with COVID-19 pneumonia in ICU: clinical characteristics and factors influencing outcomes [0.03%]
ICU中新冠肺炎肺炎免疫抑制患者的临床特点及影响预后的因素分析
Flavia Galli,Edoardo Forin,Ana Motos et al.
Flavia Galli et al.
Introduction: COVID-19 severely impacted global health, especially older adults and those with comorbidities. Immunosuppressed patients are at high risk for severe outcomes, yet studies yield conflicting mortality rates f...